Functional Evaluation of the Visual Pathway in Patients with Multiple Sclerosis Using a Multifunction Stimulator Monitor

Table 2

Electrophysiological parameters (standard deviation) in patients with multiple sclerosis and healthy controls, as measured with the Monpack One device.

Electrophysiological parameters	MS patients	Controls
mfVEPs (nV/deg^2)
Central	798.80 (585.58)	1556.81 (1120.9)	<0.001
Superonasal	504.00 (278.84)	637.95 (675.843)	0.455
Superotemporal	533.31 (292.29)	579.58 (341.27)	0.610
Inferonasal	523.90 (262.71)	798.50 (390.14)	0.001
Inferotemporal	677.55 (730.19)	830.40 (380.09)	0.003
Pattern ERG
N35 latency (msec)	27.18 (29.31)	23.82 (5.34)	0.515
N35 amplitude (mV)	−0.70 (1.34)	−0.62 (2.45)	0.534
P50 latency (msec)	46.59 (10.05)	43.34 (15.17)	0.471
P50 amplitude (mV)	4.43 (4.79)	7.21 (11.32)	0.097
N95 latency (msec)	83.09 (21.06)	71.07 (25.97)	0.070
N95 amplitude (mV)	−3.27 (5.38)	−4.79 (6.30)	0.184

Bold letters indicate statistical significance (). Abbreviations: MS, multiple sclerosis; mfVEPs, multifocal visual evoked potentials; ERG, electroretinogram.